Skip to content
Ansuman Satpathy, MD, PhD

Ansuman Satpathy, MD, PhD

Parker Bridge Scholar; Assistant Professor, Pathology


Ansu Satpathy is a physician-scientist in the Department of Pathology at Stanford University School of Medicine. Dr. Satpathy’s research focuses on developing new genome sequencing technologies to study immune system function and dysfunction directly in cancer patients. His work employs both single-cell and three-dimensional genome sequencing tools to study the epigenetic regulation of tumor-specific T cells. Dr. Satpathy completed his M.D. and Ph.D. degrees at Washington University in St. Louis in the Medical Scientist Training Program. His graduate research in the Department of Immunology identified new functions of dendritic cells in immune responses to pathogens and tumors. He then completed clinical residency training in pathology at Stanford Hospital, followed by postdoctoral research in epigenomics in the laboratory of Dr. Howard Chang.

Education & Training

  • 2005: King’s College London, United Kingdom, Biomedical Sciences
  • 2006: University of Illinois, Urbana, IL, BS, Molecular Biology, BA, Philosophy
  • 2014: Washington University, St. Louis, MO, PhD, Immunology
  • 2014: Washington University, St. Louis, MO, MD
  • 2017: Stanford University, Residency, Clinical Pathology

Awards & Honors

  • 2017: Bridge Scholar, Parker Institute for Cancer Immunotherapy
  • 2016: Irvington Postdoctoral Fellowship, Cancer Research Institute
  • 2013: David M. Kipnis Award for outstanding dissertation, Washington University in St. Louis
  • 2012: Predoctoral Fellowship, American Heart Association
  • 2008: Medical Student Teaching Excellence Award, Washington University in St. Louis
  • 2006: Medical Scientist Training Program (MSTP), NIH

Get Email Updates